What is NDC 24208-602?

24208-602 is the product NDC for Prolensa (bromfenac sodium), Bromfenac sodium .7 mg/mL solution/ drops, listed with the FDA by Bausch & Lomb Incorporated. It has 3 package NDCs, shown above in 10- and 11-digit form.

Bausch & Lomb Incorporated, NDC labeler code 24208. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Prolensa?

None: this is the only finished product listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Prolensa NDC 24208-602 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)24208-602Labeler and product segments. Claims need a package NDC.

Product NDC at billing width24208-0602Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package
24208-602-03	2420806020324208060203	1 BOTTLE, DROPPER in 1 CARTON (24208-602-03) / 3 mL in 1 BOTTLE, DROPPERMarketed from Apr 5, 2013
24208-602-04	2420806020424208060204	1 BOTTLE, DROPPER in 1 CARTON (24208-602-04) / 3 mL in 1 BOTTLE, DROPPERMarketed from Apr 5, 2013
24208-602-06	2420806020624208060206	1 BOTTLE, DROPPER in 1 CARTON (24208-602-06) / .6 mL in 1 BOTTLE, DROPPERMarketed from Apr 5, 2013 · Sample package

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Prolensa
Generic name (nonproprietary): bromfenac sodium
Active ingredients: Bromfenac sodium — .7 mg/mL
Dosage form: Solution/ drops
Route: Ophthalmic
Labeler: Bausch & Lomb IncorporatedNDC labeler code 24208
Product type: Prescription drug
Marketing category: NDA — New Drug ApplicationApplication NDA 203168
Marketing start: Apr 5, 2013
Listing expires: Dec 31, 2027
Other FDA classes: Non-Steroidal (Chemical structure)Cyclooxygenase Inhibitors (Mechanism)
Identifiers: Product ID 24208-602_5114fa15-9db8-23b9-e063-6294a90ad057SPL ID 5114fa15-9db8-23b9-e063-6294a90ad057SPL set ID 4e072537-f73c-4a96-a65f-e2805ce112d8RxCUI 1375917, 1375922UNII 8ECV571Y37
Pharmacologic class: Nonsteroidal Anti-inflammatory Drug

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Ophthalmic products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N424208060203 followed by a unit qualifier and the quantity

Package 24208-0602-03. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective May 5, 2026.

Indications (excerpt from the label)

PROLENSA ® is indicated for the treatment of postoperative inflammation and reduction of ocular pain in patients who have undergone cataract surgery. PROLENSA is a nonsteroidal anti-inflammatory drug (NSAID) indicated for the treatment of postoperative inflammation and reduction of ocular pain in patients who have undergone cataract surgery. ( 1 )

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 24208-602

What is NDC 24208-602?: 24208-602 is the product NDC for Prolensa (bromfenac sodium), Bromfenac sodium .7 mg/mL solution/ drops, listed with the FDA by Bausch & Lomb Incorporated. It has 3 package NDCs, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Prolensa (Bromfenac Sodium).
What is the active ingredient?: Bromfenac sodium.
Who is the labeler?: Bausch & Lomb Incorporated, NDC labeler code 24208. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Prolensa?: None: this is the only finished product listed under this name.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other NDCs under NDA 203168

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under NDA 203168
Product	Strength	Form · route	Labeler	Product NDC
bromfenac ophthalmic solutionbromfenac sodium	Bromfenac sodium .7 mg/mL	Solution/ dropsOphthalmic	Dr. Reddy's Laboratories Inc.	75907-093
bromfenac ophthalmic solutionbromfenac sodium	Bromfenac sodium .7 mg/mL	Solution/ dropsOphthalmic	Bausch & Lomb Americas Inc.	82260-602

Prolensa (Bromfenac sodium) NDC 24208-602